Literature DB >> 22229581

Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson's disease.

Maria Antonietta Panaro1, Antonia Cianciulli.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of dopamine neurons in the substantia nigra pars compacta. To date, although a bulk of evidences suggest that the etiology of PD is multifactorial, none of the mechanisms yet proposed have been considered conclusive. Activated glia seem to play a critical role in the degeneration of nigral dopaminergic neurons in PD, by secreting a complex array of cytokines, chemokines, proteolytic enzymes, reactive oxygen/nitrogen species and complement proteins that may have deleterious effects on the dopaminergic system. Recently, it has been reported that microglia activation and immunity are key factors contributing to disease progression. Here, we review studies on the role of inflammation mediated by the innate and adaptive immune systems involved in the pathogenesis of PD and highlight some of the important areas for future investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22229581     DOI: 10.2174/138161212799040574

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  22 in total

1.  Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.

Authors:  Haiyan Fu; Aaron S Meadows; Tierra Ware; Robert P Mohney; Douglas M McCarty
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

2.  Conserved and species-specific transcription factor co-binding patterns drive divergent gene regulation in human and mouse.

Authors:  Adam G Diehl; Alan P Boyle
Journal:  Nucleic Acids Res       Date:  2018-02-28       Impact factor: 16.971

3.  Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a Mouse Model of Neurodegeneration.

Authors:  Maria Antonietta Panaro; Alessandra Aloisi; Giuseppe Nicolardi; Dario Domenico Lofrumento; Francesco De Nuccio; Velia La Pesa; Antonia Cianciulli; Rosaria Rinaldi; Rosa Calvello; Vania Fontani; Salvatore Rinaldi
Journal:  Neurosci Bull       Date:  2017-11-10       Impact factor: 5.203

4.  Exosomes-associated neurodegeneration and progression of Parkinson's disease.

Authors:  Isabella Russo; Luigi Bubacco; Elisa Greggio
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

5.  Pesticides, microglial NOX2, and Parkinson's disease.

Authors:  Thomas Taetzsch; Michelle L Block
Journal:  J Biochem Mol Toxicol       Date:  2013-01-24       Impact factor: 3.642

6.  Neuron-derived IgG protects neurons from complement-dependent cytotoxicity.

Authors:  Jie Zhang; Na Niu; Bingjie Li; Michael A McNutt
Journal:  J Histochem Cytochem       Date:  2013-08-26       Impact factor: 2.479

7.  Complement expression in the retina is not influenced by short-term pressure elevation.

Authors:  Konstantin Astafurov; Cecilia Q Dong; Lampros Panagis; Gautam Kamthan; Lizhen Ren; Anna Rozenboym; Tarique D Perera; Jeremy D Coplan; John Danias
Journal:  Mol Vis       Date:  2014-01-31       Impact factor: 2.367

8.  Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation.

Authors:  Eiron Cudaback; Xianwu Li; Yue Yang; Thomas Yoo; Kathleen S Montine; Suzanne Craft; Thomas J Montine; Christopher Dirk Keene
Journal:  J Neuroinflammation       Date:  2012-08-10       Impact factor: 8.322

Review 9.  Immunology primer for neurosurgeons and neurologists part 2: Innate brain immunity.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2013-09-18

10.  Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.

Authors:  Beatriz Moreno; Iciar Lopez; Begoña Fernández-Díez; Miroslav Gottlieb; Carlos Matute; María Victoria Sánchez-Gómez; María Domercq; Albert Giralt; Jordi Alberch; Kevin W Collon; Helen Zhang; Jack M Parent; Meritxell Teixido; Ernest Giralt; Valentín Ceña; Inmaculada Posadas; Eva Martínez-Pinilla; Pablo Villoslada; Rafael Franco
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.